University of Aberdeen logo

AURA - Aberdeen University Research Archive

 

Mirabegron versus placebo and other therapeutic modalities in the treatment of patients with Overactive Bladder Syndrome : A Systematic Review

dc.contributor.authorDey, Anirban
dc.contributor.authorGeorgiadis, Georgios
dc.contributor.authorUmezurike, Justin
dc.contributor.authorYuan, Yuhong
dc.contributor.authorFarag, Fawzy
dc.contributor.authorN'Dow, James
dc.contributor.authorOmar, Muhammad Imran
dc.contributor.authorMamoulakis, Charalampos
dc.contributor.institutionUniversity of Aberdeen.Other Applied Health Sciencesen
dc.contributor.institutionUniversity of Aberdeen.Academic Urology Uniten
dc.contributor.institutionUniversity of Aberdeen.Institute of Applied Health Sciencesen
dc.date.accessioned2025-09-16T23:09:28Z
dc.date.issued2024-09-28
dc.description.statusPeer revieweden
dc.format.extent14
dc.format.extent533887
dc.identifier293490551
dc.identifiere10b2d27-cb22-4303-9cc6-8366b90a633d
dc.identifier85205264555
dc.identifier39343691
dc.identifier.citationDey, A, Georgiadis, G, Umezurike, J, Yuan, Y, Farag, F, N'Dow, J, Omar, M I & Mamoulakis, C 2024, 'Mirabegron versus placebo and other therapeutic modalities in the treatment of patients with Overactive Bladder Syndrome : A Systematic Review', European Urology Focus. https://doi.org/10.1016/j.euf.2024.09.012en
dc.identifier.doi10.1016/j.euf.2024.09.012
dc.identifier.issn2405-4569
dc.identifier.otherORCID: /0000-0001-5340-0081/work/168605986
dc.identifier.otherORCID: /0000-0002-1597-3126/work/168607671
dc.identifier.urihttps://hdl.handle.net/2164/26028
dc.language.isoeng
dc.relation.ispartofEuropean Urology Focusen
dc.subjectMirabegronen
dc.subjectOveractive bladder syndromeen
dc.subjectRandomised controlled trialsen
dc.subjectUrgency urinary incontinenceen
dc.subjectNocturiaen
dc.subjectImidafenacinen
dc.subjectTolterodineen
dc.subjectSolifenacinen
dc.subjectOxybutyninen
dc.subjectPreferred Reporting Items for Systematic Reviews and Metaanalysesen
dc.subjectR Medicine (General)en
dc.subjectSupplementary Dataen
dc.subjecthttps://ars.els-cdn.com/content/image/1-s2.0-S2405456924001810-mmc1.docxen
dc.subject.lccR1en
dc.titleMirabegron versus placebo and other therapeutic modalities in the treatment of patients with Overactive Bladder Syndrome : A Systematic Reviewen
dc.typeJournal articleen

Files

Original bundle

Now showing 1 - 1 of 1
Thumbnail Image
Name:
Dey_etal_EUF_Mirabegron_versus_placebo_AAM.pdf
Size:
521.37 KB
Format:
Adobe Portable Document Format

Collections